The Food and Drug Administration today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor neurons with a healthy one. . . . → Read More: FDA Approves Rare Infant Disease Gene Therapy
|
|||||
|
|
A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M 
A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss. . . . → Read More: Start-Up to Use Stem Cells for Hearing Loss 
Results from a clinical trial show patients recovered from their hernia surgeries with non-opioid pain medications, and stayed off opioids for 15 days. . . . → Read More: Trial Shows Surgical Pain Managed Without Opioids 
An analysis of genomes for all varieties of tomatoes, both wild and domesticated, found a rare gene variation that can make tomatoes tastier. . . . → Read More: Genomic Analysis Finds Lost Tomato Taste Gene 
A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs. . . . → Read More: Company Helps Labs Build Gene, Cell Therapy Businesses 
The Food and Drug Administration issued its final guidance on regulating the interchangeability of so-called biosimilars with original biologic drugs. . . . → Read More: FDA Issues Final Biosimilar Guidance 
Results from a clinical trial show a peptide derived from scorpion venom illuminates brain tumor cells making removal of the tumors easier for surgeons. . . . → Read More: Scorpion-Derived Peptide Lights Up Brain Tumors  One comment - (Comments are closed)  New products  Australia, biomedical, biotechnology, cancer, chemistry, clinical trials, life sciences, pharmaceuticals, physical sciences 
A collaboration between biopharmaceutical maker Gilead Sciences and biotechnology company Goldfinch Bio aims to develop precision medicines for treating various kidney diseases. . . . → Read More: Companies Partner on Kidney Disease in $2B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, stem cells 
A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease. . . . → Read More: Start-Up to Use Crispr for Heart Disease, Gains $59M One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, entrepreneurs, equity, genomics, heart disease, investment, licensing, life sciences, pharmaceuticals, university, venture capital |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||